EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study-Reference-Cited by-同舟云学术

EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study

Published:2012-01 Issue:1 Volume:13 Page:33-42
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Pirker Robert,Pereira Jose R,von Pawel Joachim,Krzakowski Maciej,Ramlau Rodryg,Park Keunchil,de Marinis Filippo,Eberhardt Wilfried EE,Paz-Ares Luis,Störkel Stephan,Schumacher Karl-Maria,von Heydebreck Anja,Celik Ilhan,O'Byrne Kenneth J

Publisher

Elsevier BV

Subject

Oncology

Reference31 articles.

1. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial;Pirker;Lancet,2009

2. Personalized medicine in non-small-cell lung cancer: is KRAS a useful marker in selecting patients for epidermal growth factor receptor-targeted therapy?;Roberts;J Clin Oncol,2010

3. Targeted therapies: biomarkers in NSCLC for selecting cetuximab therapy;Stinchcombe;Nat Rev Clin Oncol,2010

4. Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study;O'Byrne;Lancet Oncol,2011

5. Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor;Kimura;Cancer Sci,2007

Cited by 512 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation on the cost–effectiveness of Cetuximab in treatment of colorectal cancer: a systematic review;Colorectal Cancer;2024-08-27

2. Rediscovering immunohistochemistry in lung cancer;Critical Reviews in Oncology/Hematology;2024-08

3. Differential expression of epidermal growth factor receptor in various pathological types of salivary gland cancers;Auris Nasus Larynx;2024-08

4. Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma;Translational Research;2024-06

5. Clinicopathological and immunohistochemical characteristics of bullous pilomatricoma: a retrospective, single-center study, and comparison with ordinary pilomatricoma;Anais Brasileiros de Dermatologia;2024-05